scispace - formally typeset
R

Richard Lawrence

Researcher at University of Texas Health Science Center at San Antonio

Publications -  57
Citations -  3287

Richard Lawrence is an academic researcher from University of Texas Health Science Center at San Antonio. The author has contributed to research in topics: Glutathione & Telomere. The author has an hindex of 29, co-authored 57 publications receiving 3185 citations. Previous affiliations of Richard Lawrence include University of Texas at San Antonio.

Papers
More filters
Journal Article

Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells.

TL;DR: The results suggest that relevant biological effects of porphyrins can be achieved at concentrations that do not have general cytotoxic effects on cells, and support the concept that a rational, structure-based approach is possible to design novel telomere-interactive agents with application to a selective and specific anticancer therapy.
Journal ArticleDOI

Dietary n‐3 Fatty Acids Decrease Osteoclastogenesis and Loss of Bone Mass in Ovariectomized Mice

TL;DR: FO decreased bone loss in ovariectomized mice because of inhibition of osteoclastogenesis and this finding supports a beneficial effect of FO on the attenuation of osteoporosis.
Journal ArticleDOI

Oxidative Stress and AP-1 Activity in Tamoxifen-Resistant Breast Tumors In Vivo

TL;DR: The results suggest that the conversion of breast tumors to a tamoxifen-resistant phenotype is associated with oxidative stress and the subsequent antioxidant response and with increased phosphorylated JNK and c-Jun levels and AP-1 activity, which together could contribute to tumor growth.
Journal ArticleDOI

In vitro antitumor activity of the novel marine agent, Ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patients

TL;DR: The data from the cloning assay indicate that the duration of exposure to ET-743 is an important factor in human tumors, and long-term exposure to the novel compound may be preferred in future clinical trials.